Axsome Therapeutics (AXSM) Earnings Analysis

Axsome Therapeutics (AXSM) next reports earnings on 2026-08-10, consensus EPS -0.8938 USD. Last quarter (2026-05-04) it missed with EPS -1.26 USD vs -0.85 USD est (-48.2%). It has beaten estimates in 4/7 recent quarters (57%). Trailing P/E -64.24.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does AXSM next report earnings?

Next earnings date2026-08-10
Consensus EPS estimate-0.8938 USD
Revenue estimate0.22B

AXSM earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-04-1.26 USD-0.85 USD-48.2%Miss
2026-02-23-0.71 USD-0.7 USD-1.4%Miss
2025-11-03-0.94 USD-0.82 USD-14.6%Miss
2025-08-04-0.92 USD-1 USD+8%Beat
2025-05-05-0.8 USD-1.26 USD+36.5%Beat
2025-02-18-0.96 USD-1 USD+4%Beat
2024-08-05-1.24 USD-1.3 USD+4.6%Beat

Beat rate: 4/7 (57%) over reported quarters with consensus data.

AXSM valuation and analyst view

Trailing P/E-64.24
Trailing EPS-3.67791 USD
Price / book224.74
Dividend yield0.00%
Market cap12.27B
Analyst consensusBuy (25 buy / 1 hold / 0 sell)
Avg price target276.89 USD

Related research pages

Frequently asked questions

When is Axsome Therapeutics (AXSM)'s next earnings date?

Axsome Therapeutics is next scheduled to report on 2026-08-10, with a consensus EPS estimate of -0.8938 USD and revenue estimate of 0.22B.

Did AXSM beat earnings last quarter?

In its 2026-05-04 report, AXSM posted EPS of -1.26 USD versus a -0.85 USD estimate — a miss of 48.2%.

What is AXSM's earnings track record?

Over the last 7 reported quarters with consensus data, AXSM beat estimates 4 times (57%).

What is AXSM's current P/E ratio and EPS?

AXSM trades at a trailing P/E of -64.24 on trailing EPS of -3.677911567031195 USD.

What do analysts rate AXSM?

Analyst consensus is "Buy" across 26 ratings (0 strong buy, 25 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 276.89 USD.